Oncologyservicesinsudan 131117165510 Phpapp01

The Sudanese Medical Association (SMA) UK & Ireland
Oncology Services in Sudan: Realities and

Ambitions
Conference Report
December 17th , 2012
Medani, Gezira State,
Sudan
A joint conference of the Sudanese

Medical Association (UK & Ireland) and
the National Cancer Institute in Medani,
Sudan in collaboration with the
Sudanese Oncology Society
Suggested Citation:
Ahmed M., Ali Z., El Higaya E., Ibrahim N., Flavin A. and Abuidris D.O. (2013). Oncology
Services in Sudan: Realities and Ambitions, Conference Report. Sudanese Medical Association UK
& Ireland.
©Sudanese Medical Association UK & Ireland 2013
All rights reserved. Requests for permission to reproduce or translate SMA UK & Ireland
publications (whether for sale or for non-commercial distribution) should be addressed to SMA UK
& Ireland, at the below address.
The mention of specific names, organizations, companies or of certain manufacturers’ products does
not imply that they are endorsed or recommended by SMA UK & Ireland in preference to others of a
similar nature that are not mentioned. Errors and omissions are expected. The names of proprietary
products are distinguished by initial capital letters.
All reasonable precautions have been taken by SMA UK & Ireland to verify the information
contained in this publication. However, the published material is being distributed without warranty
of any kind, either expressed or implied. The responsibility for the interpretation and use of the
material lies with the reader. In no event shall SMA UK & Ireland be liable for damages arising
from its use. Information concerning this publication can be obtained from:
Sudanese Medical Association (SMA) UK and Ireland
No.9 Ros Caoin, Roscam. Galway,
Ireland
Or
P O Box 80. Morden Surrey. SM4 9AS. UK
Copies of this publication can be ordered from:www.sma-ukandireland.org/info@sma-

ukandireland.org
1 Oncology Services in Sudan : Realities and Ambitions December 2012

TABLE OF CONTENTS
Table of Contents 2
Abbreviation 4
List of Tables and Figures 5
Introduction 6
Executive Summary 8
Conference Sessions 15
Overview of the NCI 16
Overview of the Rick 19
Overview of Shandi Oncology Centre 20
22
Cancer Statistics in Sudan and Gezira State
23
Overview of cancer Registry Services In Sudan
24
Overview of the KBCC
Cancer Diagnostic in Sudan 24
Advocacy: Cancer Survivors Group 26
Development of a National Cancer Centre Model: Standards and 27

Challenges
28
Radiotherapy Services in Ireland: What Sudan Can Learn
Developing Cancer Strategy in Under-resourced Health System: 30

Challenges and Opportunities

Sudan –Ireland Collaboration: The Potential of Institutional 32
Partnership to Improve Health Services
34
From Dublin to Madani: The SMA initiatives in Cancer Health Care
Conference Recommendations 36
Annex 38
Appendix 1: Conference Programme 39
Appendix 3: Photo Gallery 42
Appendix 2: IAEA Recommendations 46

ABBREVIATIONS
Sudanese Medical Association

SMA
National Cancer Institute

NCI
Radiation and Isotopes Centre in Khartoum

RICK
International Agency for Research on Cancer

IARC
International Atomic Energy Agency
IAEA
WHO World Health Organisation
U of G University of Gazira
GCR Gezira Cancer Registry
SJH St James’s Hospital , Ireland
NCHD Non Consultant Hospital Doctor
HLA Human Leukocyte Antigen
KBCC Khartoum Breast Care Centre
RCSI Royal College of Surgeons Ireland
RCPI Royal College of physicians Ireland

LIST OF TABLES AND FIGURES
Figure 1 Gezira University established 1975.
Figure 2 Map showing the seven localities of Gezira state.
Table 1 Incidence rate of the total number of cancer cases in 2008
Table2 Number of cancer cases treated at Shandi Centre of Nuclear

Medicine and Oncology (2009-2012)
Figure 3 Departments of Shandi Centre of Nuclear Medicine and
Oncology
Figure 4 Contributing data sources to National Cancer Registry
Figure 5 National cancer registry common cancers percentages

(overall and by gender)
Figure 6 Khartoum Breast Care Centre, KBCC
Figure 7 Principles of Irish Oncology Services planning
Figure 8 Conceptual framework for assessing access to health

services (ADAY. L.A. et al 1997)
Figure 9 The six building blocks of health systems
Figure 10 Focus areas for future Sudan-Ireland collaboration.
Figure 11 Initial steps in starting a new partnership

INTRODUCTION
Sudan is experiencing a growing cancer epidemic with major

challenges throughout the spectrum of screening, diagnosis, treatment and follow-
up. Some of the serious challenges in this field include high incidence of advanced,
difficult-to-treat disease at presentation, high cancer burden, limited resources
and an unequal distribution of services in a big country like Sudan.
This conference attempts to evaluate oncology services in Sudan examining all
public and private oncology centres currently operating in the country. This
comprehensive review will involve present realities, gaps in the services and future
plans.
The conference also discussed international models of oncology service

provision in the Republic of Ireland and the United Kingdom with special
emphasis on governance and quality management in the development of oncology
centres. The need to create and maintain external links for standards setting and
accreditation purposes were also highlighted. The conference was held on 17th
December 2012 in Madani Heart Centre, Gezira State, Sudan.
Sudanese Medical association (SMA):
The Sudanese Medical Association- SMA (UK&I) is an independent, non-

governmental academic organization. It was founded in February 2010 and held its
inaugural meeting in the Central Middlesex Hospital. This was attended by
Sudanese healthcare professionals based in the UK and Ireland.
The Association is aiming to be an agent of change and voice of reason by
representing the public face of Sudanese medicine and bringing healthcare
professionals together in working partnership. Membership is open to all healthcare
professionals including clinicians, dentists, nurses, pharmacists and allied healthcare
scientists. Members are committed to upholding professional values away from
political or personal motivations. Their judgment on arising issues is influenced
only by the need to develop efficient healthcare for the people of Sudan.
National cancer Institute (NCI) in Gezira state:

The National Cancer Institute (NCI) is a potential centre of excellence
established in 1992 by the University of Gezira (U of G) (Figure-1) in Wad Madani,
Sudan. U of G is a community oriented university established in 1975 with a main
objective of rural development. University of Gezira is located in the centre of
Sudan in the Gezira State, the most densely populated State after the capital
Khartoum.

EXCEUTIVE SUMMARY
The conference was organised by the Sudanese Medical Association (SMA UK &
Ireland) and the national Cancer Institute, Madani (NCI) in recognition of the
rapidly rising cancer incidence in Sudan in recent years. The objective was to
assess the current situation in the country in relation to cancer and plan for the
future learning from international experience. All the important components of
cancer control including registration, prevention, screening and early detection as
well as diagnosis and treatment were addressed.
National Presentations: An overview was provided by the Sudanese speakers on

the history of the service in Sudan, the current situation, the issue of cancer
registration, gaps in the services and future plans and aspirations.
An overview of the current situation and future plans for NCI were presented by
Dr Elhaj. He spoke of the dramatic rise in cancer cases in Sudan since 1999 and
highlighted the national issues related to diagnosis of cancer particularly the lack
of diagnostic facilities. The lack of access of cancer patients to radiotherapy is also
an issue with just one cobalt machine for a population of 4 million catering for
approximately 1300 new patients seen annually. Despite these difficulties the
centre has been at the forefront of epidemiological research and has been involved
in many training workshops with international collaborators. The hospital has
established a regional cancer registry with the support of IARC. Currently in
association with the University of Gezira MSc programmes in Molecular Biology,
Medical Physics and Nuclear Medicine Technology are provided. Plans for the
future include more inpatient beds, establishing surgical oncology, upgrading
radiotherapy equipment, training of staff and strengthening research.

Dr Sedik Mustafa provided an overview of the RICK. The centre has witnessed the
huge rise in cancer incidence in Sudan. When it opened in 1967, 250 patients per
year were seen and treated compared with 7500 in 2011. The staff is well trained,
most having trained in Europe and kept up to date with regional training courses
provided by IAEA and other organisations. There is a lack of radiotherapy
equipment as the centre has only 2 cobalts and 2 linacs to deal with this volume of
patients. A big issue is a lack of ongoing maintenance of equipment which is
crucial to prevent linac downtime. Another issue identified is brain drain of
healthcare professionals
Dr Nabeel Mohamed provided an overview of services in Shandi centre. This

opened in 2009 and has an early detection programme, outpatient chemotherapy
facilities, a nuclear medicine section which has facilities for treatment of thyroid
cancers. Currently patients go to the RICK for radiotherapy although the plan is to
have a cobalt machine with simulator and treatment planning system (TPS) as well
as brachytherapy facilities in the near future. An overview was given of cancer
registration in Sudan by Drs Dafaalla Omer Abuidris (NCI) and Dr Ahmed Hashim
(NCR Khartoum).
Cancer registration was initiated in NCI in 2006 as the first attempt to create a
population based registry in Sudan. The NCI provides most of the data and Dr
Abuidris highlighted the challenges obtaining data from general hospitals as well
as the issues around death certification with many patients who die from cancer
dying at home rather than in hospital. The data collected demonstrates that the
commonest cancers in Sudan are breast, haematological malignancies and prostate
cancer.
Dr Hashim spoke of the National Cancer Registry NCR in Khartoum. This has
been re-established in 2009. The NCR is a population based register in Khartoum
state, the largest state in Sudan. Training has been provided for staff in the

registries with support from international partners. A big issue is the lack of
understanding by policy makers of the importance of cancer registration in terms
of planning for the current and future needs of a country in relation to cancer
control.
Dr Wafaa Elhadi provided an overview of the facilities in the Breast Care Centre
Khartoum. This is a not for profit institute which opened in 2010 and focuses on
diagnosis and treatment of breast cancer. Surgical and chemotherapy treatments are
available. The numbers of patients treated here is gradually increasing.
Professor Ahmed MohaMadani presented an overview of the situation regarding

pathological diagnosis of cancer in Sudan. He focussed on the importance of
accurate diagnosis to the appropriate treatment of cancer. He dealt with the need
for investment in pathology so that immunohistochemistry and cytogenetics as
well as cytology and frozen section are available for therapeutic and prognostic
information. He highlighted the importance of both internal and external quality
assurance in pathology. Currently in Sudan accreditation of pathology laboratories
is voluntary but his view was that standards would be improved by mandatory
accreditation and external peer review.
Mr Ahmed Abuzaid, a cancer survivor presented some of the issues patients have
with access to treatment, overcrowded services. He was positive however about the
fact that treatments are free in the public centres.
The main challenges identified by the local speakers were:
*Lack of a good registration systems for cancer cases
*Lack of access to good diagnostic facilities and good peer review systems to
avoid errors in diagnosis
*Lack of access to radiotherapy due to machine shortage and lack of any

radiotherapy in certain parts of the country
*Lack of maintenance of radiotherapy equipment.
*Brain drain of healthcare staff
The International speakers discussed international models of service delivery and

how Sudan could learn from experience elsewhere in relation to developing a
sustainable service into the future. The need to create and maintain sustainable
external links for setting of standards and developing a quality service was
highlighted.
Mr Ian Carter, Senior Health manager, HSE Ireland discussed the development of
a National Cancer Control Programme (NCCP) from a health manager’s
perspective. He spoke of the importance of planning the development of the
service. The allocation of funding and resources in his view were critical to
success. He highlighted the need to focus on the entire population using evidence
based strategies for all aspects of cancer control from registration to palliative care.
He spoke of the challenges that had been faced in Ireland in the past with a
fragmented service and evidence of poor outcome in comparison with European
neighbours. Centralization of services had been implemented following the
recommendations of the NCCP with cancer centres capable of providing full range
of diagnostic and therapeutic facilities as well as ancillary services needed by
cancer patients such as physiotherapy, dietetics etc.. He emphasized the importance
of maintaining standards within the programme by means of internal and external
quality assurance.
Dr Aileen Flavin, a Consultant Radiation Oncologist spoke on the development of

Oncology services in Ireland and what Sudan might learn from Irish experience.
The outcome of cancer patients in Ireland had been poor in comparison with other
EU countries for many years. In response to this a National Plan for Radiation
Oncology (NPRO) and a National Cancer Control Programme were published in

2006. Recommendations have since been implemented that have made dramatic
changes to the delivery of cancer services in Ireland. Improvements in cancer
survival have been seen in parallel with these changes. The national nature of the
programme which looked at the needs of the population as a whole has been
integral to its success. Political support was critical as funds were allocated and
ring-fenced for cancer. Strong leadership was needed and the appointment of a
director of the NCCP drove many of the changes that were needed to implement
the programme.
Dr Faisel Mihaimeed, Director of Cancer Surgery in St Barts Hospital, London,

UK provided an overview of the global burden of cancer with a focus on the
situation in low income countries where cancer incidence is dramatically
increasing. He spoke of the disparity between Africa and the developed world in
relation to survival of cancer patients particularly childhood cancers. He
discussed some of the reasons for this including lack of access to radiotherapy
treatment. He spoke of the particular challenges encountered in countries like
Sudan with inadequate registration of cancer cases, lack of awareness of cancer
symptoms due to lack of education of the population, lack of trained personnel to
deal with cancer due to “brain drain” as well as limited access to diagnostic and
treatment facilities. In his view prioritizing cancer prevention is the most important
priority in cancer control in Sudan given the lack of access to diagnostics and
treatment.
Dr David Weakliam, Head of the Irish Forum for Global Health, HSE, Ireland
presented on Sudan-Ireland collaboration and the potential of institutional
partnerships to improve health services. He spoke of the history of Irish-Sudanese
co-operation with Irish involvement in humanitarian programmes in Sudan and
Sudanese healthcare professionals working in the Irish healthcare system. He
highlighted the potential of institutional partnerships to improve healthcare in both
countries. The rapidly increasing incidence of cancer in Sudan in his view made it

an important disease to focus on. He discussed the principles of Irish Aid which
are built on namely partnership, public ownership and transparency, effectiveness
and quality assurance, coherence with a particular focus on creating long term
programme sustainability. He discussed the factors that lead to effective
institutional partnerships with a shared vision being a critical factor. Other factors
leading to successful partnerships included the importance of partners getting to
know each other, developing incrementally and clear communication between
partners. He discussed European Esther Alliance of which Ireland is a member of
whose goal it is to improve health in developing countries.
Finally Dr Mohamed Ahmed, Vice-president of the SMA spoke on the SMA

initiatives in Cancer Control. He provided an overview of the St James Hospital
(SJH) initiative supported by the SMA that aims to build capacity through training
of individuals. He spoke of the potential of an institutional partnership as per
ESTHER alliance model to twin SJH with the NCI. He identified potential sources
of support for this project including the Irish Cancer Society (ICS) as well as the
Irish Forum for Global Health (HSE)
Recommendations from the conference
1: There is an urgent need to provide specialized cancer treatment centres which

incorporate the three modalities of cancer treatment( surgery, radiotherapy and
chemotherapy) to serve the wider population of Sudan particularly areas remote
from Khartoum
2: Funding for establishing these needs to be allocated and ring fenced
3: A strategy needs to be developed to train, employ and retain appropriate cancer

healthcare professionals.
4: In order to plan for the future in terms of planning services a nationwide cancer
registration programme needs to be established.

5: Support should be provided from MOH to establish sustainable institutional
links between NCI and overseas institutions such as SJH for training of cancer
healthcare professionals as well as maintaining standards.

Conference sessions

Overview of the NCI, Madani
Dr. Ahmed Elhaj , NCI Madani
In his presentation in the conference; Dr. Elhaj gave an overview about NCI
which was established in 1995 to meet the community needs in the fields of
Oncology, Nuclear Medicine and Molecular Biology. It is one of the clinical and
research medical institutes of the University of Gezira. The institute has six
departments including departments of Nuclear Medicine, Oncology, Molecular
Biology, Medical Physics and Engineering, Diagnostic Imaging and department of
Medical Laboratories.
NCI was established with the following vision:
1- Treatment and prevention of cancer.

2- Use of modern technologies of nuclear, molecular and imaging diagnostics.
3- Research in endemic diseases and cancer.
4- Training of Sudanese and African doctors, scientists, technologists and
researchers.
NCI has a large network of connections with international organizations and

with many similar local, regional and international institutes. This network
includes institutes form; Africa (Egypt, South Africa, Zimbabwe); Asia (Syria,
Jordan, Pakistan, India); and Europe (Italy, France, U.K., Germany, Sweden). NCI
has established relations with the International Agency for Research on Cancer
(IARC). IARC is one of the WHO agencies based in Lyon, France. NCI
Collaborated with IARC in establishing a population-based Gezira Cancer
Registry. NCI has a long standing collaboration with the International Atomic
Energy Agency (IAEA) of the United Nations. The IAEA has kindly provided NCI
with technical support in terms of technology transfer and capacity building of the
human resources of the institute. As a result, NCI has played a significant role in
technology transfer for the service of the community, and is now recognized as a
referral centre for advanced diagnostic methods in nuclear medicine, molecular
biology and medical imaging not only in Sudan but in the whole East African
region. It has been recognized as a central laboratory for HLA typing for Sudan
which enabled NCI to provide the service to other African countries as well.

Figure 1: Gezira University established 1975.
NCI has designed training programmes for short courses as well as full
degrees. The areas covered so far are; molecular biology, nuclear medicine
technology and medical physics. Three post graduate programmes are approved by
the University of Gezira. These include the following:
1- MSc/PhD in Molecular Biology.

2- MSc in Medical Physics.
3- MSc in Nuclear Medicine Technology.
NCI staff has developed a good expertise in various epidemiological research

of cancer illnesses as well as tropical diseases such as Malaria and Schistosomiasis.
Environmental and genetic determinants of several diseases were the focus of a
number of studies. NCI researchers are extending this knowledge to conduct
epidemiological cancer studies taking into account the potential impact of
infectious diseases on cancer aetiology. In the last five years, NCI has organized a
number of workshops and conferences. Notably, is the conference of the CRTC,
which was held in Madani, Sudan in June 2004. The theme of the conference was:
"CRTC: an Initiative for Cancer Prevention and Advancement of Health Research
in Sub-Saharan Africa". The NCI has also organised short training courses on
recent advances in haematological malignancies in collaboration with consultants
from Queen Elisabeth hospital in the UK. NCI has established the Gezira Cancer
Registry (GCR) with the support of IARC which provided the necessary soft ware
and training for the registry personnel.
Cancer in Gezira state:
In Sudan, diagnosis of cancer is only performed in Khartoum and Gezira due

to the huge shortage in diagnostic facilities. Cancer treatment is generally

expensive, and most of the patients cannot afford such costs in a health system that
predominantly relies on its finance on out-of pocket payments. Cancer has now
become among the top ten killer diseases in Sudan. Among females, breast cancer
is on the top of the list (34.5%) followed by cervical cancer (14.3%). Among
males, prostate cancer is the top killer. Twenty-fold increase in numbers of
reported cases was observed since the first cancer centre was established in
Khartoum in 1967. National Health Insurance covers only investigations and
surgical procedures for limited number of cancer patients. The Government of
Sudan supports the poor people through social support fund which is currently
covering the chemotherapy cost only. However, public budget is clearly inadequate
for cancer prevention and other treatment modalities, medical supplies and for
provision of sufficient human resources.
Figure 2: Map showing the seven localities of Gezira state.
The total number of patients who attended NCI so far exceeded 20,000 with
about 1300 new patients annually. It covers seven localities in Gezira state as
shown in figure-2 with details of cancer cases and population from the year 2008
in table-1. Future development plans for NCI include; building of 110 bedded
wards, establishing surgical oncology service, strengthening of research
capabilities of the institute, manpower development and the improvement of the
existing facilities for cancer treatment.
Locality Populatin NO of cancer cases Incidence

rate
El Kamleen 401930 66 13

El hasahisa 606389 509 84
El managil 906216 193 21
Madani El kubra 423865 1226 289
Janub Elgezira 555250 866 156e
Sharg Elgazira 463154 327 71
Total 3575280 3265 673
Table 1: Incidence rate of the total number of cancer cases in 2008
Overview of the Service Provision in radiation & Isotope centre,

Khartoum (RICK)
Dr. Sediek M. Mostafa, Radiation and Isotopes Centre, Khartoum (RICK)
The Radiation and Isotopes Centre in Khartoum (RICK) was established in

1967 as the first cancer treatment centre in Sudan. The number of new cases seen
in RICK jumped from 250 in 1967 to 7500 cases in 2011. As a result of this
increasing pressure, there was more demand for more specialized centres for
cancer treatment. The NCI Madani was established in 1995. The two centers
(Marawi & Shandi) have building constructed and equipments contracted but
awaiting supply, installation and commissioning. There are planned centers for El-
Fashir (Darfur), El-Obied (Kordofan) and Gedarif. Funding has been secured for
the former of these centres.
During 1960s and 1970s, RICK’s radiotherapists, nuclear medicine physicians,

physicists, engineers, technologists and nurses were trained in Europe. Further
training and techniques updating are generally offered through courses, with IAEA
experts, scientific visits and CME courses. Brain drain of expensively trained
qualified staff remains to be a major problem facing RICK. Equipment
maintenance is another important challenge and despite the emergency funding

from the government, RICK is still in urgent need for $900,000 to update all
current equipments and replacing deteriorated components and out dated software.
Overview of Shendi Oncology Centre
Dr. Nabeel Mohamed, Shandi Centre of Nuclear Medicine and Oncology,

University of Shandi.
Shandi Centre of Nuclear Medicine and Oncology commenced providing
services in September 2009 as the third oncology centre in Sudan, after
considerable efforts from local community leaders, university directors and
political support. The hospital building which consists of four complexes is under
construction since January 2010 figure-3. It consists of four complexes. As shown
in table-2 the centre had treated nearly 500 cases since establishment in 2009.
Tumor Type Number of

Patients
Breast 112
Prostate 85
Thyroid 73
Cervix 57
Nasopharynx 38
Osophagus 32
Rectum 22
Brain 15
A.L.L 11
HCC 7
RCC 4
Lung 3
Total 459
Table2: Number of cancer cases treated at Shandi Centre of Nuclear

Medicine and Oncology (2009-2012)

The centre provides different health services for people living in River Nile state
through the following five departments as shown in figure-4:
Figure 3: Departments of Shandi Centre of Nuclear Medicine and Oncology
1. Oncology Department (clinic): Started in 2009 bi-weekly referring clinic.

Patients were referred to Khartoum Centre (RICK) to receive radiotherapy.
2. Early Detection Unit: Started in June 2010, mainly breast and uterine cervix
cancers. It consists of: Laboratory, Ultrasound machine and Minor Theater for
biopsy.
3. Chemotherapy Unit: Started in May 2010. It consists of a hall of 10

chemotherapy beds and pharmacy for preparation and dispensing of doses for
patients.
4. Nuclear Medicine Department: Started in March 2010. It consists of imaging

unit with Single Head SPECT Gamma Camera (MEDISO). This department has a
rradioactive Iodine unit with four isolated rooms.
5. Radiotherapy Department: It consists of Cobalt 60, Conventional Simulator,

TPS, and mould room.
Cancer Statistics in Sudan, Gezira State
Dr. Dafaalla Omer Abuidris, Dean, NCI, Madani

Hospital-based registry gives only rough estimation. There is huge potential to
lose record of many cancer patients in Sudan as some are unable to reach the
scarce cancer centres due to economical or accessibility reasons, others may die
before referral and many may not be diagnosed at all due to cost of diagnostic
process and referral system deficiencies. Some patients may be diagnosed but
decline referral and may seek alternative medicine pathways due to cultural beliefs.
Gezira cancer registry (GCR) was established in 2006 as the first attempt to
create a population-based cancer registry in Sudan. Sources of data includes:
Oncology hospitals (NCI & RICK), main general hospitals in Gezira, main state
and private pathology labs and expert reports. The contribution is so far
predominated by the hosting location in NCI as shown in Figure-6. The weight of
data provided by NCI in the cancer registry represents more than half of the data.
There is significant difficulty obtaining data from general hospitals. Moreover,
information on mortality is difficult to trace as most patients with cancer die at
home in the absence of structured palliative and terminal care institutions and
hospices. One of the possible future solutions is to establish regional registries.
This requires provision of sufficient budget and human resources. Ongoing work in
registry will improve the quality of data and mortality can become easy to estimate
through use of advanced telecommunication technologies.
Figure 4: Contributing data sources to National Cancer Registry
As shown in Figure-7 findings from the five-year registry report in Sudan

(2011) showed that total number of cases is 5762, of which 3177 were females.
The most common tumor was breast cancer (1012) which constituted 17.6% of all
cancers and just more than 30% of female cancers. Hematological cancers were the
second commonest. The second commonest solid tumor was prostate (368) which
constituted 14.3% of all male cancers.

Figure 5 National cancer registry common cancers percentages (overall and
by gender)
Overview of the Cancer Registry Services in Sudan
Dr. Ahmed Hashim, Cancer Registry in Khartoum
The first national cancer registry started in 1967 in Khartoum with data
collected through the department of Pathology in the Faculty of Medicine,
University of Khartoum. This cancer registry functioned well until the early 1980s
when it stopped due to lack of funds. Cancer registry unit was launched at the NCI
in 2006, and the National Cancer Registry (NCR) was re-established in 2009 as
there was a necessity for cancer registries in all 17 states as a prerequisite for the
national cancer control programme. The NCR is a population-based registration in
Khartoum State as the biggest state and the capital of the Sudan. The main
objective of the NCR is to develop a system that will facilitate all the steps and
processes of creating and maintaining local and regional cancer registries and
pooling them into a single central and accessible system. Reporting sources
includes passive case finding through hospitals and Radiotherapy centers that
employed registry officers to report cases with cancer & send the data to NCR.
Active case finding is done through data obtained from private clinics and
pathology laboratories that allow the registry officers to identify and access
relevant data during routine visits. In April 2010 a dedicated building was allocated
for national cancer registry and may health facilities in Khartoum state were
surveyed & focal points for these facilities were designated for registration of
cancer cases. Subsequently a universal registration form was designed & piloted
and registration booklets were distributed to private health facilities.
Training was provided for statisticians in Khartoum, River Nile, Northern

Kordofan and Northern states. Further training was also provided for registry cadre
in France, England and South Africa in cancer registration. A new branch of cancer
registry was established in Northern state.
The building of a comprehensive cancer registry is faced with many problems

including poor awareness of policy makers in Sudan about the importance of
cancer registration, the lack of funding for expanding cancer registration in remote
states; the poor capacity of cancer diagnosis in remote states e.g. lacks of standard
pathology services and the lack of funding for surveys and screening of cancer.
The future plans aim to achieve the following targets including training of human
recourses (data management staff, registration officers, medical registrars).
establishment of information networking with regional and international
organizations, cancer registries and databases, expansion of cancer registry in all
other states, production of regular biannual report, development of standardized
pathology reporting system and improvement of cancer registry information
system.
Overview of the services in Breast Care Centre , Khartoum
Dr. Wafaa N Elhadi;

KBCC started in October 2010 and it is not-for-profit institution. There has been a
significant increase in number of patients served by Khartoum Breast cancer centre
(KBCC). This is clearly reflected in the increased number of patients who received
chemotherapy (164 in 2011 compared to 330 in 2012). During 2012, a total of
2789 new patients were seen, investigated and provided with treatment compared
to 1814 in 2011.

Figure 6: Khartoum Breast Care Centre, KBCC
Cancer Diagnostics in Sudan
Prof. Ahmed MohaMadani ,Gezira University

Regional reference laboratories are needed (one in each state). Intermediate
laboratories (at least 50 km apart) and all highly specialised tests are done in
regional laboratories. The private sector is definitely providing great help. The
laboratory services needs accreditation which is so far voluntary but essential. It is
better to seek international recognition and accreditation. It involves regular visits
and subsequent certification with reaccreditation is done periodically (every 3-4
years). The cost is a main barrier and needs national and international support.
Laboratory techniques relevant to cancer care that need equipment, training and
standardisation were discussed including cheap and quick tests as cytology which
is needs a lot of experience and frozen section that needs special equipment ready
to provide intra-operative assistance to expensive tests as Cytogentics that needs
especial training and equipment, is becoming essential for accurate classification
for prognostic and therapeutic decisions. Immunohistochemistry tests were also
discussed with their two types including tests performed to determine cell
differentiation and used for diagnostic purposes and tests that are not related to
morphology but are used for prognostic and predictive purposes as (HER2/neu,
ER/PR).
Advocacy : Cancer Survivors Group

Mr. Ahmed Abuzaid
Mr. Abuzaid explored the difficulties faced by Cancer patients in Sudan such
as access to services, waiting times and overcrowded services. He also illustrated
the benefits that patients receive such as free radiotherapy and chemotherapy
interventions in public oncology centres in Sudan. Mr. Abuzaid showed a
documentary film of recovery stories of a number of patients with cancer in Sudan.
Development of a National Cancer Centre Model: Standards and

Challenges
Mr. Ian Carter, Senior Health Manager, Health Services Executive (HSE),
Ireland
Mr. Carter started his talk by the description of a model for a National
Cancer System that addresses issues including National Control planning, Funding
and resource allocation, overall systematic design (top down, focus on population
as whole, adoption of evidence-based strategies for prevention, early detection,
diagnosis, treatment and palliation, selection of treatment options with their cost
implications comparing efficiency and effectiveness of different modalities,
establishing a National data registry that can help in subsequent outcome and
performance evaluation and Impact analysis through a National clinical audit
programme.

Mr. Carter also discussed guidelines for establishing a model that should
adopt a population-based health system approach that recognises and addresses
inequalities with emphasis on health promotion, prevention and early detection. It
should recognize key areas of focused interventions as tobacco control, and
addresses the provision of population based and opportunistic screening
programmes adopting simple, safe, precise, validated & cheap tests with prompt
linkage to a treatment pathway if test was positive through a system that provides
effective treatment and interventions with multimodality coordination of Surgery,
Chemotherapy and Radiation Oncology. Optimally, the service setting should
allow for analytical ability through randomised trials to detect effectiveness of
interventions.
In Ireland Oncology services structural reform requirements generally entail that
hospital cancer centres to have internal capacity and capability to satisfy
population base of 500,000 with provision of full range of general medical and
surgical services including pathology, laboratory, radiology, critical surgical
subspecialty services, medical oncology, curative and palliative therapies working
within multidisciplinary teams. It should also provide a full range supporting staff
as Full Range Palliative and Specialist Nurses, Dietetic, Physiotherapy Services,
Counselling Services, Clinical and Compounding Pharmaceutical Services, Social
Work Services. It should be able to provide training facilities for specialty training
for health professions and research facilities including clinical trials. It should have
the capacity to measure adherence and compliance with treatment protocols;
maintain satisfactory quality assurance process, active engagement in accreditation
a close linkage with higher education institutions and an effective linkage with
Primary Care. Future collaboration can cover the following areas
• International Cooperation, collaboration and partnership.
• Comparison and evaluation of incidence & treatment outcomes.
• Quality Assurance Collaboration, licensing, accreditation and external

validation.
• Research partnership and education and learning opportunities.
Radiotherapy Services in Ireland: What Sudan might learn from

Ireland

Dr. Aileen Flavin; Consultant in Radiation Oncology, Cork University
Hospital, HSE, Ireland
Dr. Flavin started her presentation by giving an overview of the main seven
principles on which Oncology services development plans were based in Ireland
shown in figure 8. She described the transformational plan of cancer service
development that focussed on the establishment of four supra-regional centres
including two in the capital Dublin, one in Cork city in the south and a fourth in
Galway city in the west. Each centre will have access to all three modalities of
treatment (surgical, medical and radiation Oncology) in multidisciplinary care with
access to acute services. Regarding the radiotherapy component each centre should
have at least four radiotherapy treatment Linac units with a total of just below 40
Linacs in the country whole country serving a population with over four millions.
The current Radiation Oncology services in Ireland are provided by 28 Radiation
Oncologists treating 29,745 patients per year achieving a 5-year survival rate of
about 55%.
Figure 7: Principles of Irish Oncology Services planning
The National Plan for Radiation Oncology in Ireland (NPRO) 2006

recommended to have a national network of six facilities providing services under
four large centres: two in Dublin and one in each of Cork and Galway with two
integrated satellite centres in Waterford and Limerick (managed by Cork and
Galway, respectively). Patients in the North-West region can have their care
affiliated to Belfast in North Ireland. Since the publication of NPRO in 2006
access has improved and national approach and collaboration in many areas such
as prostate brachytherapy and stereotactic radiotherapy has been developed with
collaboration with research: Radiotherapy trials portfolio and in 2012, National
Guidelines radiotherapy was developed for common tumours.
Dr. Flavin showed that although Ireland has a good cancer registry, cancer
outcome in Ireland is worse than European neighbours and radiotherapy services in
Ireland are under-utilised with some difficulties in access and lack of
multidisciplinary working in some centres. Private centres in Ireland are not
completely integrated in the national network so far. She then proposed potential
areas that can be adopted by Sudan from Irish experience including the necessity
for a national approach in the context of national cancer control plan. She flagged
the concern improving radiotherapy may not have a major impact as high
percentage of cancers would be advanced at the time of diagnosis. It is essential to
have a functioning updated National Cancer Registry that helps in knowing extent
of the problem to aid planning for future services with appropriate infrastructure
with particular attention to equal access. The assistance of IAEA and WHO should
be sought in developing a national cancer control plan for which the WHO
document (Developing a National Cancer Control Plan) is an important resource.
Developing Cancer Strategy in the under resourced Health

System: Challenges & Opportunities
Dr. Faisal Mihaimeed: Director of Cancer Surgery, Barts Health NHS Trust,
London, UK
Dr. Mihaimeed gave an overview of global cancer burden accounting for

12.5% of all deaths worldwide with more cancer attributed deaths than those die as
result of HIV/AIDS + TB + Malaria combined with the expectation of annual
incidence of 15 million new cases every year diagnosed globally by 2020. 70% of
the newly diagnosed cases will be in developing countries, where governments are
least prepared to address the growing cancer burden. Survival rates in developing
countries (such as Sudan) are often less than half those of more developed

countries. Over one third of cancer deaths are due to preventable causes such as
viral infection, poor nutrition and widespread tobacco use. In Africa, on average
5% of childhood cancers are cured, compared to nearly an 80% cure rate in the
developed world.
Life-saving radiotherapy is available in only 21 of Africa’s 54 countries, or to less
than 20% of the population of Africa. The combined effects of cancer, poverty,
deprivation and infectious diseases in many African countries, hinder the
development of a sustainable population and consequently a sustainable future.
Efforts to improve these poor cancer-related indicators in developing countries
are faced with considerable challenges including:
1\ Inadequate data collection and registration of diagnostic and therapeutic

procedures and outcomes.
2\ Lack of awareness and education in a population with significant illiteracy rates

needs to be carefully addressed. Efforts need to be made to get the message that
cancer can be treated if it is discovered and treated early.
3\ Human resources shortage is one of the major challenges confronting cancer

services with massive brain drain and frequent immigration to the neighbouring
Gulf States with attractive irresistible financial reward.
4\ Limited access to technology necessary for accurate diagnosis and effective

therapy and even secure data storage and analysis.
In this complicated environment to establish new up-to-date services facing

these challenges that are deeply rooted and difficult to overcome in a context of
poor socioeconomic status, prioritizing cancer prevention activities may be of
greater importance than countries well equipped to address the complexities of
providing a comprehensive cancer care service from early detection, diagnosis,
treatment, follow up and even terminal care. Preventive measures include:
• Improving awareness
• Encouraging people to adopt of healthy lifestyles
• Smoking control interventions as smoking is the single largest preventable risk
factor for cancer.
• Excessive alcohol consumption is strongly linked to an increased risk of several
cancers.
• Vaccination is now available specifically for cervical cancer.
Figure 8: Conceptual framework for assessing access to health services (ADAY.
L.A. et al 1997)
Sudan-Ireland collaboration: the potential of institutional

partnerships to improve health services
Dr. David Weakliam; Chair of the Irish Forum for Global Health, HSE, Ireland
Dr. Weakliam started his presentation by the stressing the importance of a

functioning health systems that is essential to deliver health services and
interventions and the need for capacity building of key health institutions as a
critical element in developing cancer services. He suggested that there are
opportunities for Sudan-Ireland collaboration to provide an example for a North-
South institutional partnership as an effective means to build the capacity of health
institutions in developing countries. He described the six building blocks of a
health system shown in Figure-9.

Figure 9: The six building blocks of health systems
Dr. Weakliam discussed the opportunity for partnership with Sudan in the
development of cancer services with emphasis on the need for leadership
involvement and commitment as vital prerequisite, supporting the national
strategy, provision of prevention and early detection services, diagnosis and
treatment facilities and palliative care. He also addressed need for partnership in
organisation and management aspects and sharing learning on best practice
particularly from model centres of excellence that can provide guidelines,
protocols and tools for information to be nationally used in satellite branch centres.
He described eight areas of focus for the potential future collaboration as shown in
figure-10. And described initial steps required when building a new partnership as
shown in figure-11
Figure 10: Focus areas for future Sudan-Ireland collaboration

Figure 11: Initial steps in starting a new partnership
From Dublin to Madani: The SMA initiatives in Cancer Health

Care
Dr. Mohamed Ahmed; Vice president of the SMA Ireland
Dr. Ahmed gave an overview of St. James’ Hospital (SJH) Initiative that aims to
build institutional capacity through training of individuals. SJH could assist in
providing guidance in many areas including identification of strengths, planning to
improve provision and utilisation of resources, accreditation cycle through training,
support and peer review, mutual visits and placements for Sudan health
professionals in SJH, providing a twinning model similar to the European
ESTHER Alliance model that Ireland joined in Feb 2012 and provides institutional
capacity building activities through twinning between hospitals of the North and
hospitals in developing countries. The twinning should meet certain criteria and
allows provision of some funding. This conference is a platform to create such
links for the future twinning between the Oncology divisions in SJH-Ireland &
NCI, Madani-Sudan. Potential support can be sought through the Irish Cancer
society. Irish Cancer Society is a charity organization and a strong advocate for
improving Irish cancer services. It is the main provider of cancer information for
prevention, detection, treatment and support in Ireland. It provides large numbers
of information leaflets & booklets in simple language. The SMA UK & Ireland got
Irish cancer Society permission to translate all of their Cancer info material into
Arabic. Translated booklets and leaflets will be available in Sudan in both
electronic and paper formats. The Irish Forum for Global health will provide
logistic & advisory support to the project in Ireland.

CONFERENCE RECOMENDATIONS
There is an urgent need to provide more specialised cancer treatment centres (with
3 modalities of treatment) to serve the wider population of Sudan especially in
areas distant from Khartoum such as Kordofan, Darfur and East of Sudan.
Funding for establishing such centres should be provided and ring fenced.
Human resources policy to train, employ and retain health professionals in the area
of cancer treatment.
A nationwide cancer registry programme should be established in Sudan in view of

the current fragmented registry services in Khartoum and Madani.
The National Cancer Registry should undertake epidemiological studies

investigating prevalence and burden of cancer diseases.
The outcomes of such studies should help in planning cancer services in a cost-
effective model.
Sudan is developing a national cancer control strategy and this provides an

appropriate framework for collaboration. Support provided by Irish institutions
should be in line with Sudan's national strategy.
There are good reasons to establish a direct institutional link with the NCI. It
already serves a large population base. It is well placed to develop services with
the new hospital being built, good institutional leadership, committed doctors and
strong community/political support. Its throughput is less that of RICK so there is
plenty of scope to expand services. In order to achieve better outcomes there is a
need to shift from late treatment/palliation to early detection and treatment.
While there are many institutions in Ireland which could provide support it makes
sense for NCI to establish a strong link with one institution, i.e. SJH. Through this
link connections can be made with other centres and organisations as indicated
(e.g. National Cancer Control Programme, Cancer Registry)

It is appropriate to focus initially on oncology services. However opportunities to
support the full range of services should also be considered over time - i.e.
including prevention, early detection and palliative care.
In order to develop an appropriate programme to support services development at

NCI, it would be important for senior clinical staff to visit and get exposure to
cancer centres and services in Ireland. SJH (Ian Carter) has offered this invitation
and will further communicate with NCI. We should be mindful that Sudan will not
exactly follow the Ireland model - for instance nursing and AHP staff play a more
limited role in Sudan and it will take some time to strengthen their role and
develop a multidisciplinary team approach. Through a visit to Ireland, NCI
clinicians will get insights into what can be strengthened in Sudan and a
programme can be tailored accordingly.
An institutional linkage with SJH offers the potential for a range of service quality
improvement measures, from individual training to institutional accreditation. Up
skilling of existing staff is a priority as the IAEA report identified that current
staffing levels are adequate. Training could include short visits to learn a
particular skill (few weeks - month) or longer for more formal training
programmes (e.g. certified nursing course).
Access to specialist training for doctors in oncology/radiation oncology is not

feasible due to the very limited places in Ireland. An option worth exploring is
whether Sudanese doctors could be facilitated to fill vacant service posts on a time
bound contract and get some recognition for experience and participation in
training activities. There would be a reciprocal benefit to Ireland through the
filling of vacant NCHD posts. This would require discussion with the HSE and the
respective training bodies (RCSI, RCPI and Sudan Medical Specialisation Board).
Something similar has been tried in the UK.

Annex

Conference Programme

Photo Gallery

Meeting with the Minister of Health in Gezira State
Meeting with NCI Clinical Team

Meeting with the Vice President of University of Gezira
One of the conference sessions

One of the conference sessions
The visit to NCI, Madani

IEA Report

Diagnosis and Treatment of Cancer in Sudan: IAEA Report
Diagnosis and treatment of cancer in Sudan is managed primarily at three centres,

including the Radiation and Isotopes Center Khartoum (RICK), National Cancer
Institute and Shandi Cancer Center. There are some cancer-related services
provided at secondary and tertiary hospitals, and notably less at the primary
level. The referral system for cancer in Sudan is also noted to be weak.
Efforts are being made by the government to scale up cancer services at the
primary health care level, notably in prevention and early detection. A pilot study
is being undertaken from 2012-2013 to integrate cancer services in seven states
into primary health care. Training Tools, provision of supplies and training
courses are included in this plan.
Under its Cancer Advisory Committee within the Federal Ministry of Health,
two standard case management protocols for breast and prostate cancer have been
established. However, it was noted that these have not yet been widely distributed
due to lack of funds for publication
and distribution.
Encouragingly, interest on the part of investors to establish and strengthen

health facilities has been demonstrated recently. For instance, an extension of
RICK (opening of the Amil, or ‘Hope’ Tower) was made possible three years ago
through a US $6.7 million grant from the Islamic Development Bank. Many of
these projects are responsible for inviting foreign experts for short periods of
time to Sudan. However, a challenge facing Sudan is the often dramatic currency
fluctuations that serve as an obstacle to investors.
Most cancer-related services are available for free or are relatively

inexpensive. Missing diagnostic investigations are referred to private centers,
which can be up to 300 times more expensive. Some tests have a waiting list of
up to three weeks. Of the approximately 10 000 new cancer patients diagnosed in
Sudan every year, RICK receives an estimated 7 000 – 8
000 patients while another 1 300 are seen in NCI.
As earlier mentioned, there are published treatment protocols for breast and
prostate cancers. However, these protocols are not widely distributed to
oncologists, and as result, recommendations are often not followed.
Radiation and Isotopes Centre Khartoum (RICK)
RICK is the main referral center, treating the largest number of cancer cases
in Sudan. Almost fifty per cent of female cancers seen at RICK are breast (25-
30%) and cervix (12%). The predominantly prevailing male cancers are 17-20%
prostate, 10-12% head and neck followed by cancers of the oesophagus.
Instituted in 1967, RICK recently underwent an expansion due to a grant

provided by the Islamic Development Bank (IDB). The Amil Tower (‘hope’ in
Arabic) is connected to RICK and was instituted three years ago. There are 100
beds for patients. The department of radiation oncology has four external
beam machines (two linear accelerators, two Co 60). The external beam
machines work in three shifts starting from 6:00 a.m. to 2:00 a.m. for the Co-60
machines (shifts begin at 8:00 a.m. for the linear accelerator). On a typical day,
190 - 200 patients are treated on all machines. The waiting period ranges from
one day to three months depending on curative or palliative intent. Seventy per
cent of patients are treated with palliative intent and the remaining thirty per
cent curative. The department has one HDR brachytherapy BEBIG machine. Staff
at RICK stated that repair and maintaining uptime of radiotherapy equipment
is a challenge. As there is neither a maintenance contract nor budget for
maintenance of equipment, machines can sometimes be out of order for several
months at a time leading to insufficient radiotherapy provided to cancer patients.
A quality assurance programme for radiotherapy is in place at RICK.The staff is

comprised of 25 radiation oncologists, 65 radiation technologists, 10 medical
physicists and 10 biomedical maintenance engineers.
With regards to nuclear medicine, RICK is equipped with a SPECT gamma

camera, a radioiodine facility, isolation rooms, and staffed with four nuclear
medicine specialists and 16 nuclear medicine technologists. In diagnostic
radiology, RICK has two conventional X-ray machines, an ultra-sonography
machine, CT machine, three radiologists and five technologists.
There are an estimated 500 paediatric cancer cases per year in Sudan, of which 40
percent are treated at RICK. There are fourteen paediatric beds available, and
another eight were being prepared to be opened at the time of the mission.
Roughly 30 paediatric patients are seen per day. For chemotherapy, eighty beds
are available for male and female patients. Chemo radiation is being used for 25
patients daily. Overall, 140 - 150 patients receive chemotherapy daily. Cancer
patients requiring surgery are referred and undertake procedures outside RICK.
The clinical pharmacy started in 2007.

National Cancer Institute (NCI)
The NCI at the University of Gezira (formerly the Institute of Nuclear Medicine
Molecular Biology and Oncology – INMO) has been in operation for thirteen
years and provides cancer services. The NCI is based in Wad Madani, roughly
three hours from Khartoum. NCI features two buildings, one of which is
currently undergoing a US $18 million construction for expansion of the
hospital. The new building will be comprised of five floors and 120 beds. Once
completed, the centre will have capabilities in chemotherapy, surgery, radiation,
operation theatres, palliative care and iodine therapy (as a part of nuclear
medicine). The centre also has a hospital-based cancer registry which seeks to
cover the four million people living within Gezira State (of the 30 million total
population of Sudan, as per 2008 census), in addition to surrounding states. The
radiology department is equipped with one MRI scan investigating 20 patients
per day and one ultrasound machine testing 25 patients daily. Conventional
radiology is also available. The radiology staff includes two specialists and six
radiographers.
The nuclear medicine department is equipped with one gamma camera and one
SPECT. The staff is comprised of two specialists, four radiographers, two
pharmacy technicians and one radiopharmacist.
NCI also has a well-equipped molecular laboratory with four machines for tissue
typing, used primarily for renal transplant, liver transplant and dialysis. The
laboratory has also analyzed tumour markers and hormone profiles. There is
one pathology laboratory that conducts routine pathology studies (including
blood studies). Six staff members work in the laboratory.
Regarding radiotherapy, the centre is equipped with one Co-60 machine operating
daily from 8:00 a.m. to 6:00 p.m. which treats sixty patients daily. The waiting
list is one week for patients beginning radiation therapy. Treatment and dose
schedules are radical and curative for fifty per cent of patients and palliative for
the remaining half. The centre does not have a brachytherapy machine and a
request to the IAEA has been put forth for a high-dose rate brachytherapy
machine. An old LDR machine has not been functional for the past ten years.
According to 2011 data, the centre treats an estimated 1 300 patients per year with
radiation.
Much like RICK, staff at NCI noted difficulties in keeping equipment up and
running on a consistent basis. There are no budgets or maintenance contracts in
place for the majority of equipment at NCI. There are no trained service
engineers on staff at NCI who are able to repair any out of service equipment
and obtaining maintenance from abroad under the present circumstances remains a
challenge. A quality assurance programme for radiotherapy is established at NCI.
The centre is equipped with 15 dedicated chemotherapy beds. Chemotherapy is
provided at no cost to the patient and an average of 25 patients is seen daily. NCI
presently has 47 inpatient beds for males and females. The centre has two
paediatric oncologists who are treating one hundred patients annually.
For male and female patients receiving treatment at NCI, a 50-bed boarding
house is made available for longer-term stays and is located in the vicinity of the
hospital. The house hosts a kitchen for patients and families staying at the
facility, and offers patients (who sometimes travel from neighbouring countries) a
chance to finish treatment while remaining on site.
Shandi Cancer Centre
Shandi Cancer Centre is a university based center. Shandi University Hospital has

one clinic, the ‘older’ Shandi Centre, which treats an estimated 375 new
cancer cases per year (an estimated 75 of these cases are referred from RICK).
Diagnosis services (except for nuclear medicine) are located in the hospital
campus. Hematology, parasitology, microbiology and histopathology laboratories
(no immunohistochemistry) are well equipped and staffed.
Radiology services include conventional X-ray, ultrasound and CT scan; a

radiologist and three technologists make up the staff. There is neither a
mammography unit in the hospital nor a colposcopy unit.
The nuclear medicine service is located in the cancer unit. The facility is
equipped with a gamma camera and staffed by two technologists, one medical
physicist and one nuclear medicine physician (currently training in Egypt). A
very small number of cases are seen, since only one Technetium99 generator per
month is procured from Turkey.
Surgery is mostly performed at the surgical departments of the hospital or in

Khartoum and then sent for chemotherapy and follow up in Shandi. The center
has a chemotherapy service that is run by one clinical oncologist who travels
from Khartoum once per week, typically examining 30 patients per visit. The
service is a day care service with 15 beds and a centralized area for
chemotherapy preparation (with a laminar flux cabin). One clinical pharmacist
and three nurses treat 10-12 patients per day. There is currently no radiotherapy
service at the center. Two oncologists are currently in training.
Though not yet ready to receive cancer patients, the Shandi Cancer Center has a
new campus under construction. Consisting of five buildings, the new centre is

about to open. In the new facility (located outside of the university hospital
campus), the main building will host radiotherapy and chemotherapy services.
Radiotherapy equipment has already been procured and consists of one
“Equinox” cobalt therapy unit, one conventional simulator, a 2D treatment
planning system (TPS) and a brachytherapy unit (with cobalt sources). Staff for
this service will be available when the centre opens, and will be comprised
of two clinical oncologists, two medical physicists, and two RTTs. A nuclear
medicine service will also be added to the treatment facility. The new center will
have two inpatient wards, a day care unit for oncology ambulatory treatment and
radiology department.
Additional Sites
Khartoum Teaching Dental Hospital is a government hospital that treats

250 patients annually with head and neck cancers. Most head and neck cancers
that present at the hospital are late-stage cancers among men aged 31-40 and are
referred to RICK for radiation and chemotherapy. Cases requiring surgery are
seen by three head and neck surgeons who perform complex resections and
reconstructions at the hospital. The hospital has four operating rooms and 50
beds. In 2006, 155 cancer patients were seen at the hospital. Two- hundred and
fifty were seen in 2011, and raise of awareness among the population about ‘the
bad disease’ (as cancers is sometimes referred to among the general population) is
seen as the cause.
Rabat University has an ambitious plan to construct a US $14 million cancer

center in Khartoum. To date, land has been secured for the project though lack of
funding has delayed the project.

Khartoum Breast Center is a privately owned, state of the art breast centre that
commenced operations last year. Staff from the centre claimed that they suffer
from currency fluctuations and few patients, since many nationals who can afford
treatment prefer travelling abroad.
The breast center in Khartoum Hospital opened in 2005 which has four
surgeons and four medical oncologists as staff. Most cases are advanced and
require mastectomy and/orchemotherapy. Reconstruction has been recently
introduced. There is currently a five months delay for treatment, and treatment is
not free for patients. There is no MRI capability. They refer mammography to
private centers.
Royal Care Private Centre is a private multi-specialization hospital. The

surgical department is made up of three general surgeons, one vascular
surgeon and one neurosurgeon. There is one clinical oncologist on staff
taking care of chemotherapy for referred cancer patients. Royal Care has a
clinical p harmacy department. The hospital demonstrated interest in acquiring
radiation oncology facilities. The oncologist informed the team that Royal Care’s
plan was for one linear accelerator, one planning system and one CT simulator.
Bunkers for two machines have been designated in the basement.
Alneelin Diagnostic Clinic is a private facility with nuclear medicine and radio
diagnostic capabilities. The centre has a SPECT Single Head Gamma camera,
one MRI scan, one CT Scanner, one Mammography machine, one ultrasound
(alone), one ultrasound with Doppler facility, one conventional x-ray, in
addition to endoscopy facilities (Including Gastroenterology, cystoscopy,
echo cardiography, EEG, ECG, lithotripsy and blood studies). The centre works
in two shifts and some services are available for 24 hours per day, seven day per

week. The staff included seven doctors on permanent staff and seven working on
a Shift basis.
Khartoum Maternity Hospital is the oldest and largest women’s hospital in

Sudan. The hospital has one gynecologist oncologist on staff. The hospital gives
special attention to the early detection of cervical cancer.
3.7 Assessing Sudan’s Radiotherapy Needs
When devising a radiotherapy plan, it is advised that the plan be designed in

phases based on the quantity and complexity of the equipment and the human
resources needed. The plan specific for radiotherapy should be integrated within
the larger National Cancer Control Plan. According to GLOBOCAN 2008 data,
there are 21 860 new cancer cases in Sudan per year. As it is recognized that
60% of patients will require radiotherapy during the course of treatment,
approximately 13 116 cancer patients will need treatment annually.
Sudan presently has two linear accelerators and three Co-60 machines in working
order for a population of 30 million. However, these machines are present in
only two centres in two adjacent states (Khartoum and Gezira) and do not cover
the whole population. The impact team endorses the government’s plan to develop
five new centres with additional machines to meet the radiotherapy needs of
Sudan.
Since one radiotherapy machine can treat an estimated 500 patients per year, it
is foreseen that 26 radiotherapy units would be required to serve the needs of
cancer patients in Sudan. However, the requirement of 26 teletherapy units is
made on the assumption that all patients with cancer in Sudan would seek
treatment. At present, the number of patients in Sudan seeking treatment with
radiotherapy (and other interventions) is expected to be less than those expressed
by GLOBOCAN estimates due to the following reasons:
• Access, whether geographic or economic. Given the large distances that
patients must travel across Sudan to seek treatment, many patients may not have
the financial means to support transportation costs. Further, patients and families
must have sufficient financial resources to arrange for accommodation and
other requirements for the duration of treatment in Khartoum or Wad Madani;
• Sub–prescription of treatment, often attributable to the lack of specialized
knowledge by doctors in charge a patient’s treatment; and
• Overcapacity of radiotherapy treatment centres. Often, overloaded
radiotherapy centres cannot accommodate a large influx of patient demand, or
must delay treatment for patients who present at late stages of disease. As per
IAEA staffing recommendations (one radiation oncologist per 250-300 new
patients), radiation oncologist staff is adequate in both RICK and NCI (25
radiation oncologists for 7000+ patients at RICK and three oncologists at NCI for
1300 patients), though a continuous professional development program needs to
be instituted so that trained staff can be retained. The number of radiation therapy
technologists is adequate as per IAEA recommendations. Given the IAEA
guidance on medical physicist staffing (one medical physicist per 400
patients), the current 15 working in Sudan would need to be coplemented to
meet a recommended 21. Staffing requirements would need to be reassessed
given the planned expansion of radiotherapy services in the country.
With respect to training and human resource development, a training programme
for radiation Oncologists was started in 2002 and is under the Medical Council.
Currently, 34 radiations Oncology registrars are under training; of those, nine
are in their final year. Fifteen such Students have graduated from the programme
in the last five years. Medical physicists also receive training and obtain a Master’s
of Science Degree. The radiation therapy technologist course is offered and is of
four years duration. Under the programme, training is conducted in both radio-
diagnosis and therapy.
The IAEA provides guidance on the assessment of radiotherapy needs and further
recommendations on setting up a radiotherapy programme1.
1
1
Setting Up a Radiotherapy Programme: Clinical, Medical Physics, Radiation
Protection and Safety Aspects:http://cancer.iaea.org/documents/Ref5-
TecDoc_1040_Design_RT_proj.pdf Planning National Radiotherapy Services: A
Practical Tool: http://www-
pub.iaea.org/MTCD/publications/PDF/Pub1462_web.pdf

Oncologyservicesinsudan 131117165510 Phpapp01

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Oncologyservicesinsudan 131117165510 Phpapp01

Uploaded by

Copyright:

Available Formats

The Sudanese Medical Association (SMA) UK & Ireland

Oncology Services in Sudan: Realities and

December 17th , 2012

Medani, Gezira State,

A joint conference of the Sudanese

©Sudanese Medical Association UK & Ireland 2013

Sudanese Medical Association (SMA) UK and Ireland

No.9 Ros Caoin, Roscam. Galway,

P O Box 80. Morden Surrey. SM4 9AS. UK

Copies of this publication can be ordered from:www.sma-ukandireland.org/info@sma-

1 Oncology Services in Sudan : Realities and Ambitions December 2012

List of Tables and Figures 5

Overview of the NCI 16

Overview of the Rick 19

Overview of Shandi Oncology Centre 20

Cancer Diagnostic in Sudan 24

Advocacy: Cancer Survivors Group 26

Development of a National Cancer Centre Model: Standards and 27

Developing Cancer Strategy in Under-resourced Health System: 30

2 Oncology Services in Sudan : Realities and Ambitions December 2012

Appendix 3: Photo Gallery 42

Appendix 2: IAEA Recommendations 46

3 Oncology Services in Sudan : Realities and Ambitions December 2012

Sudanese Medical Association

National Cancer Institute

Radiation and Isotopes Centre in Khartoum

International Agency for Research on Cancer

WHO World Health Organisation

GCR Gezira Cancer Registry

SJH St James’s Hospital , Ireland

NCHD Non Consultant Hospital Doctor

HLA Human Leukocyte Antigen

KBCC Khartoum Breast Care Centre

RCSI Royal College of Surgeons Ireland

RCPI Royal College of physicians Ireland

4 Oncology Services in Sudan : Realities and Ambitions December 2012

Figure 1 Gezira University established 1975.

Figure 2 Map showing the seven localities of Gezira state.

Table 1 Incidence rate of the total number of cancer cases in 2008

Table2 Number of cancer cases treated at Shandi Centre of Nuclear

Figure 4 Contributing data sources to National Cancer Registry

Figure 5 National cancer registry common cancers percentages

Figure 6 Khartoum Breast Care Centre, KBCC

Figure 7 Principles of Irish Oncology Services planning

Figure 8 Conceptual framework for assessing access to health

Figure 9 The six building blocks of health systems

Figure 10 Focus areas for future Sudan-Ireland collaboration.

Figure 11 Initial steps in starting a new partnership

5 Oncology Services in Sudan : Realities and Ambitions December 2012

Sudan is experiencing a growing cancer epidemic with major

The conference also discussed international models of oncology service

Sudanese Medical association (SMA):

The Sudanese Medical Association- SMA (UK&I) is an independent, non-

National cancer Institute (NCI) in Gezira state:

6 Oncology Services in Sudan : Realities and Ambitions December 2012

7 Oncology Services in Sudan : Realities and Ambitions December 2012

National Presentations: An overview was provided by the Sudanese speakers on

8 Oncology Services in Sudan : Realities and Ambitions December 2012

Dr Nabeel Mohamed provided an overview of services in Shandi centre. This

9 Oncology Services in Sudan : Realities and Ambitions December 2012

Professor Ahmed MohaMadani presented an overview of the situation regarding

The main challenges identified by the local speakers were:

*Lack of a good registration systems for cancer cases